DAPTOMYCIN (DAPTOMYCIN) — FDA Approval ANDA205037 (MYLAN LABS LTD)
DAPTOMYCIN (DAPTOMYCIN) — FDA Approval ANDA205037 (MYLAN LABS LTD) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: DAPTOMYCIN; Active ingredients: DAPTOMYCIN; Application number: ANDA205037.
| Brand name | DAPTOMYCIN |
|---|---|
| Active ingredients | DAPTOMYCIN |
| Application number | ANDA205037 |
| Sponsor | MYLAN LABS LTD |
| Dosage form | POWDER |
| Route | INTRAVENOUS |
| Marketing status | Prescription |
| Products in application | 1 |
| First approval date | 20180605 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →